The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...

For the first time in three decades, researchers believe they have identified a new class of antibiotics. Teams at McMaster ...

Lariocidin was efficient against strains of E. coli, including drug-resistant ones, according to the new study.

A new study by researchers from City St George's, University of London and the Ineos Oxford Institute for antimicrobial ...

If you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially ...

For the first time in three decades, researchers believe they have identified a new class of antibiotics. Teams at McMaster University in Ontario, Canada and the University of Illinois ...

Now, a team led by researchers at McMaster University in Ontario believe they’ve found a molecule that could lead to a whole ...

The Food and Drug Administration on Tuesday approved the first drug in a new class of antibiotics for treating urinary tract infections — the first time that’s happened in nearly 30 years.

Researchers believe they have identified a new class of antibiotics, nearly three decades since the last new one came to market. Teams at McMaster University in Ontario, Canada and the University ...

The approval of gepotidacin (Blujepa; GSK) introduces the first new class of oral antibiotics for uncomplicated urinary tract ...

This antibiotic is the first new FDA-approved medication for urinary tract infections in decades, and meets the need for new ...